06:08 EST Lytus Technologies (LYT) files $75M mixed securities shelf Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter ...

The OPPO Find X8 Ultra details surface yet again, pointing at a truly powerful flagship smartphone. A trusted source shared ...

Mumbai (Maharashtra) [India], December 16: Lytus Technologies (NASDAQ: LYT), a forward-thinking platform services entity renowned for its innovation-driven business model, today announced the ...

dose-ranging trial evaluating deupirfenidone (LYT-100) at two dose levels three times a day (TID) over 26 weeks in patients with idiopathic pulmonary fibrosis (IPF). “The ELEVATE IPF trial broke ...

PureTech Health (PRTC) presented data from the dose escalation phase of its ongoing Phase 1b trial evaluating LYT-200, an anti-galectin-9 monoclonal antibody, in patients with relapsed or ...

LYT-200 is generally safe and well-tolerated as a single agent as well as in combination with standard-of-care venetoclax and hypomethylating agents LYT-200 demonstrates clinical benefit as a ...

LYT-200 is generally safe and well-tolerated as a single agent as well as in combination with standard-of-care venetoclax and hypomethylating agents LYT-200 demonstrates clinical benefit as a single ...